Harvard Corporate Governance

FEBRUARY 29, 2024

AIM ImmunoTech Inc., Companies must balance adopting provisions that provide beneficial information while being informed of the potential backlash through litigation, activist PR response (e.g., Strine, Jr. 2023-0879-LWW (Del. 28, 2023)). Crown Castle) or shareholder proposals.

146

146

Harvard Corporate Governance

FEBRUARY 1, 2024

AIM ImmunoTech, Inc. Shareholder activists should be well-apprised of this decision as it provides useful guidance on the permissible scope of ANBs that their target companies have or may adopt. On December 28, 2023, Vice Chancellor Will of the Delaware Court of Chancery rendered an important decision in Kellner v.

120

120

Reynolds Holding

JANUARY 15, 2024

AIM Immunotech Inc., December 28, 2023), Vice Chancellor Will upheld the company’s rejection of an advance notice of nomination finding that the Board acted reasonably and equitably in rejecting the notice and that it did not breach its fiduciary duties in enforcing valid advance notice bylaws. In Kellner v.

45

45

Reynolds Holding

JANUARY 8, 2023

The Securities and Exchange Commission’s (SEC’s) new universal proxy rules, which took effect for meetings after August 31, 2022, require the use of “universal” proxy cards in all director election contests, except for elections held by registered investment companies and business development companies. Notice of deadlines.

Compliance 45

Compliance 45